217 related articles for article (PubMed ID: 22075778)
1. Lipids promote survival, proliferation, and maintenance of differentiation of rat liver sinusoidal endothelial cells in vitro.
Hang TC; Lauffenburger DA; Griffith LG; Stolz DB
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G375-88. PubMed ID: 22075778
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia enhances FGF2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MEK1/2/ERK1/2 and PI3K/AKT1 pathways.
Wang K; Jiang YZ; Chen DB; Zheng J
Placenta; 2009 Dec; 30(12):1045-51. PubMed ID: 19892399
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of fatty acid synthase induces pro-survival Akt and ERK signaling in K-Ras-driven cancer cells.
Yellen P; Foster DA
Cancer Lett; 2014 Oct; 353(2):258-63. PubMed ID: 25086185
[TBL] [Abstract][Full Text] [Related]
5. Follicle-stimulating hormone-induced aromatase in immature rat Sertoli cells requires an active phosphatidylinositol 3-kinase pathway and is inhibited via the mitogen-activated protein kinase signaling pathway.
McDonald CA; Millena AC; Reddy S; Finlay S; Vizcarra J; Khan SA; Davis JS
Mol Endocrinol; 2006 Mar; 20(3):608-18. PubMed ID: 16269516
[TBL] [Abstract][Full Text] [Related]
6. Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation.
Zheng J; Wen Y; Song Y; Wang K; Chen DB; Magness RR
Biol Reprod; 2008 Jan; 78(1):143-50. PubMed ID: 17901071
[TBL] [Abstract][Full Text] [Related]
7. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
[TBL] [Abstract][Full Text] [Related]
8. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
9. HBx protein promotes oval cell proliferation by up-regulation of cyclin D1 via activation of the MEK/ERK and PI3K/Akt pathways.
Wang HY; Yang SL; Liang HF; Li CH
Int J Mol Sci; 2014 Feb; 15(3):3507-18. PubMed ID: 24577313
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration.
Tsai HR; Yang LM; Tsai WJ; Chiou WF
Eur J Pharmacol; 2004 Sep; 498(1-3):45-52. PubMed ID: 15363974
[TBL] [Abstract][Full Text] [Related]
11. Liver sinusoidal endothelial cells support the survival and undifferentiated growth of the CGR8 mouse embryonic stem cell line: possible role of leukemia inhibitory factor (LIF).
Silva-Cote I; Cardier JE
Cytokine; 2011 Dec; 56(3):608-15. PubMed ID: 21930391
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
Ripple MO; Kalmadi S; Eastman A
Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
Qiao M; Shapiro P; Kumar R; Passaniti A
J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of phosphatidylinositol-3-kinase and mitogen-activated protein kinase kinase 1/2 prevents melanoma development and promotes melanoma regression in the transgenic TPRas mouse model.
Bedogni B; Welford SM; Kwan AC; Ranger-Moore J; Saboda K; Powell MB
Mol Cancer Ther; 2006 Dec; 5(12):3071-7. PubMed ID: 17172409
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors.
Sheppard KE; Cullinane C; Hannan KM; Wall M; Chan J; Barber F; Foo J; Cameron D; Neilsen A; Ng P; Ellul J; Kleinschmidt M; Kinross KM; Bowtell DD; Christensen JG; Hicks RJ; Johnstone RW; McArthur GA; Hannan RD; Phillips WA; Pearson RB
Eur J Cancer; 2013 Dec; 49(18):3936-44. PubMed ID: 24011934
[TBL] [Abstract][Full Text] [Related]
16. Adropin is a novel regulator of endothelial function.
Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta M; Al-Omran M; Teoh H; Verma S
Circulation; 2010 Sep; 122(11 Suppl):S185-92. PubMed ID: 20837912
[TBL] [Abstract][Full Text] [Related]
17. p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway.
Kumar P; Miller AI; Polverini PJ
J Biol Chem; 2004 Oct; 279(41):43352-60. PubMed ID: 15292252
[TBL] [Abstract][Full Text] [Related]
18. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
20. Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells.
Payne KA; Meszaros LB; Phillippi JA; Huard J
Tissue Eng Part A; 2010 Dec; 16(12):3647-55. PubMed ID: 20617875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
